Validation Study of Algorithms to Identify Malignant Tumors and Serious Infections in a Japanese Administrative Healthcare Database-Reference-Cited by-同舟云学术

Validation Study of Algorithms to Identify Malignant Tumors and Serious Infections in a Japanese Administrative Healthcare Database

Published:2022 Issue:1 Volume:4 Page:20-31
ISSN:2434-4338
Container-title:Annals of Clinical Epidemiology
language:en
Short-container-title:Ann Clin Epidemiol

Author:

Nishikawa Atsushi¹,Yoshinaga Eiko¹,Nakamura Masaki²,Suzuki Masayoshi²,Kido Keiji¹,Tsujimoto Naoto¹,Ishii Taeko¹,Koide Daisuke³

Affiliation:

1. Eli Lilly Japan K.K.

2. Medical Data Vision Co., Ltd.

3. Department of Biostatistics and Bioinformatics, Graduate School of Medicine, University of Tokyo

Publisher

Society for Clinical Epidemiology

Link

https://www.jstage.jst.go.jp/article/ace/4/1/4_22004/_pdf

Reference21 articles.

1. 1. Hirano Y, Asami Y, Kuribayashi K, Kitazaki S, Yamamoto Y, Fujimoto Y. Possibility of database research as a means of pharmacovigilance in Japan based on a comparison with sertraline postmarketing surveillance. Value Health Reg Issues 2018;15:1–5.

2. 2. Pharmaceuticals and Medical Devices Agency. Revision of the Ministerial Ordinance on Good Post-marketing Study Practice (GPSP Ordinance). Pharmaceuticals and Medical Devices Safety Information, No 355. 2018. https://www.pmda.go.jp/files/000225335.pdf. Accessed Nov 20, 2020.

3. 3. Pharmaceuticals and Medical Devices Agency. Basic concepts for validating outcome definitions used in post-marketing database surveillance, PSEHB/PED, PSEHB/SD Notice. CRS Notification No 0731001, CPE Notification No 0731001. Accessed Nov 20, 2020 (In Japanese).

4. 4. Ono Y, Taneda Y, Takeshima T, Iwasaki K, Yasui A. Validity of claims diagnosis codes for cardiovascular diseases in diabetes patients in Japanese administrative database. Clin Epidemiol 2020;12:367–375.

5. 5. Koram N, Delgado M, Stark JH, Setoguchi S, de Luise C. Validation studies of claims data in the Asia-Pacific region: a comprehensive review. Pharmacoepidemiol Drug Saf 2019;28:156–170.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence of serious infections in the working‐age Japanese adult population with rheumatoid arthritis treated with tumor necrosis factor‐α inhibitors and interleukin‐6 inhibitors: A nationwide retrospective cohort study;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-06-12

2. Association of Antipsychotic Drugs with the Risk of Recurrent Venous Thromboembolism: A Retrospective Study of Data from a Japanese Inpatient Database;Drugs - Real World Outcomes;2023-11-28

3. Fibrates and the risk of cardiovascular outcomes in chronic kidney disease patients;Nephrology Dialysis Transplantation;2023-11-27

4. Validation study of case-identifying algorithms for severe hypoglycemia using hospital administrative data in Japan;PLOS ONE;2023-08-09

5. Validation studies of Japanese administrative health care data: A scoping review;Pharmacoepidemiology and Drug Safety;2023-05-14